Show news: from last 30 days (default), 60 days, 90 days, last visit or all

AWMSG approves tiotropium

14th December 2018

The All Wales Medicines Strategy Group (AWMSG) has approved the use of tiotropium (Spiriva® Respimat®) as an option for use within NHS Wales as add-on maintenance bronchodilator treatment in patients aged ≥6years with severe asthma who experienced one or more severe asthma exacerbations in the preceding year.

click here to view